In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds (Q34104471)

31 July 2017

title

In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds (English)

1 reference

31 July 2017

Dianne B Hoellman

1

1 reference

31 July 2017

Linda M Kelly

2

1 reference

31 July 2017

Kim Credito

3

1 reference

31 July 2017

Lauren Anthony

4

1 reference

31 July 2017

Lois M Ednie

5

1 reference

31 July 2017

Michael R Jacobs

6

1 reference

31 July 2017

Peter C Appelbaum

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Antimicrobial Agents and Chemotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

46

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

220-224

1 reference

Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126985

In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126985

In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against gram-positive and gram-negative bacteria

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126985

Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primates

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126985

Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126985

Mechanisms of beta-lactam resistance in anaerobic bacteria.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126985

In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126985

Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11751138

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11751138

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11751138

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.46.1.220-224.2002

1 reference

31 July 2017

1 reference

31 July 2017

1 reference